We are live on
!
Find out more
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
ONCE
Delisted
ONCE was delisted on the 16th of December, 2019.
184 hedge funds and large institutions have $3.44B invested in Spark Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 63 increasing their positions, 56 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
15% more funds holding in top 10
Funds holding in top 10: 20 → 23 (+3)
13% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 56
5% less capital invested
Capital invested by funds: $3.63B → $3.44B (-$181M)
5% less funds holding
Funds holding: 194 → 184 (-10)
29% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 34
47% less call options, than puts
Call options by funds: $109M | Put options by funds: $204M
Holders
184
Holders Change
-10
Holders Change %
-5.15%
% of All Funds
4.04%
Holding in Top 10
23
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+15%
% of All Funds
0.5%
New
24
Increased
63
Reduced
56
Closed
34
Calls
$109M
Puts
$204M
Net Calls
-$95M
Net Calls Change
-$101M
Top Buyers
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$133M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$105M |
| 3 |
PC
Paulson & Co
New York
|
+$68.1M |
| 4 |
PAM
PSquared Asset Management
Zurich,
Switzerland
|
+$27M |
| 5 |
AC
Armistice Capital
New York
|
+$18.2M |
Top Sellers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$55.1M |
| 2 |
Renaissance Technologies
New York
|
-$39.9M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$38.7M |
| 4 |
SAM
Sandell Asset Management
New York
|
-$27.6M |
| 5 |
D.E. Shaw & Co
New York
|
-$27M |
